SPA
EBS icon

Sherbrooke Park Advisers’s Emergent Biosolutions EBS Stock Holding History

Sherbrooke Park Advisers’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,757
Closed -$192K – 307
2025
Q3 		$192K Buy
+21,757
New +$169K 0.09% 390
2023
Q4 		– Sell
-41,417
Closed -$141K – 529
2023
Q3 		$141K Buy
+41,417
New +$230K 0.04% 429

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sherbrooke Park Advisers's EBS Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 21,757 shares — an estimated $192K sold.

Sherbrooke Park Advisers first reported a position in EBS in Q3 2023 and held it in 2 quarters. The position peaked at $192K in Q3 2025. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 21,757 Emergent Biosolutions shares in Q4 2025, an estimated $192K.
  • Sherbrooke Park Advisers first reported a position in Emergent Biosolutions in Q3 2023 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Emergent Biosolutions position peaked at $192K in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.